Bevacizumab in Combination With Visudyne Photodynamic Therapy (PDT)

Summary

To evaluate safety, visual acuity outcomes, persistence of choroidal neovascular leakage, and the number of treatments of combination intravitreal bevacizumab and verteporfin photodynamic therapy at standard or reduced fluence level in patients with subfoveal CNV due to age-related macular degeneration.

Timeline

Start

2006-05

Primary completion

2008-08

Completion

2009-07

Drugs

Indications